Bevacizumab mitigates codon-specific effects of trifluridine/tipiracil on efficacy outcome parameters in metastatic colorectal cancer

B. Doleschal*, H. Taghizadeh, T. Lentner, J.m. Riedl, J. Granitzer, D. Morariu, J. Decker, K.j. Aichberger, G. Webersinke, P. Kirchweger, A. Petzer, H. Rumpold

*Corresponding author for this work

Research output: Journal article (peer-reviewed) › Journal article

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Bevacizumab mitigates codon-specific effects of trifluridine/tipiracil on efficacy outcome parameters in metastatic colorectal cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science